ÂÜÀòÂÒÂ×

Erika Vojtasova is a seasoned scientist in the field of oncology and cancer biology, currently serving as a Senior Development Scientist at OxSonics Therapeutics since October 2019, after previously holding the role of Development Scientist. Erika contributed to research as a Research Associate at the University of Cambridge from February to August 2019 and completed a PhD at the same institution between 2015 and 2019. Prior academic experience includes a Master of Science in Genetics from the University of Glasgow, where Erika studied from 2010 to 2015. Additional experience includes an industrial trainee position at GlaxoSmithKline and a summer internship at the INEP Research Institute through the IAESTE program.